Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: SIMILAR MOLECULAR PATTERN IN T-AML IN PATIENTS TREATED WITH PARP INHIBITORS FOR METASTATIC OVARIAN CANCER. (September 2021)